Cell adhesion molecules as pharmaceutical target in atherosclerosis

Mini-Reviews in Medicinal Chemistry

Volumn 12, Issue 2, 2012, Pages 175-183

  Ling, S ^a   Nheu, L ^a   Komesaroff, P A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Atherosclerosis; Cell adhesion molecules; Leukocyte recruitment; Pharmaceutical therapy; Vascular endothelium

Indexed keywords

6,8 DIALLYL 5,7 DIHYDROXY 2 (2 ALLYL 3 HYDROXY 4 METHOXYPHENYL) 1H BENZO(B)PYRAN 4 ONE; ACECLOFENAC; ACETYLSALICYLIC ACID; ANTIOXIDANT; CD31 ANTIGEN; CELECOXIB; CELL ADHESION MOLECULE; CLOPIDOGREL; COLCHICINE; CYCLOSPORIN; DANTONIC; DICLOFENAC; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GINKGO BILOBA EXTRACT; GLUCOCORTICOID; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INDOMETACIN; INTERCELLULAR ADHESION MOLECULE 1; JUNCTIONAL ADHESION MOLECULE A; LORATADINE; METHOTREXATE; PENTOXIFYLLINE; S 17834; SALICYLIC ACID; SUCCINOBUCOL; T 89; TIROFIBAN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CHINESE HERB; CORONARY ARTERY DISEASE; ENZYME INHIBITION; GENE EXPRESSION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; LEUKOCYTE ADHERENCE; LEUKOCYTE AGGREGATION; LEUKOCYTE MIGRATION; LYMPHOCYTE; MACROPHAGE; MOLECULAR PATHOLOGY; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; UMBILICAL VEIN ENDOTHELIAL CELL; UNSTABLE ANGINA PECTORIS;

ANIMALS; ATHEROSCLEROSIS; CELL ADHESION; CELL ADHESION MOLECULES; HUMANS; MOLECULAR TARGETED THERAPY;

EID: 84856426593     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955712798995057     Document Type: Review

References (86)

1. Ross, R. Atherosclerosis - an inflammatory disease. New Engl. J. Med., 1999, 340,115-26.
2. Price, D.T.; Loscalzo, J. Cellular adhesion molecules and atherogenesis. Am. J. Med., 1999, 107, 85-97.
3. Blankerberg, S.; Barbaux, S.; Tiret, L. Adhesion molecules and atherosclerosis. Atherosclerosis, 2003, 170, 191-203.
4. O'Brien, K.D.; McDonald, T.O.; Chait, A.; Allen, M.D.; Alpers, C.E. Neo-vascular expression of E-selectin, ICAM-1, and VCAM-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation, 1996, 93, 672-82.
5. Davies, M.J.; Gordon, J.L.; Gearing, A.J.; Pigott, R.; Woolf, N.; Katz, D.; Kyriakopoulos, A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J. Pathol., 1993, 171, 223-9.
6. Rohde, L.E.; Lee, R.T.; Rivero, J.; Jamacochian, M.; Arroyo, L.H.; Briggs, W.; Rifai, N.; Libby, P.; Creager, M.A.; Ridker, P.M. Circulating cell adhesion molecules are corrected with ultrasoundbased assessment of carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 1998, 18, 1765-70.
7. Mulvihill, N.; Foley, B.; Crean, P.; Walsh, M. Prediction of cardiovascular risk using soluble cell adhesion molecules. Eur. Heart J., 2002, 23, 1569-74.
8. Oguchi, S.; Dimayuga, P.; Zhu, J.; Chyu, K.Y.; Yano, J.; Shah, P.K.; Nilsson, J.; Cercek, B. Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadvenlitial carotid artery injury in genetically hypercholesterolemic mice. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 1729-36.
9. Lumsden, A.B.; Chen, C.; Hughes, J.D.; Kelly, A.B.; Hanson, S.R.; Harker, L.A. Anti-VLA-4 antibody reduces intimal hyperplasia in the endarterectomized carotid artery in nonhuman primates. J. Vasc. Surg., 1997, 26, 87-93.
10. Foster, C.A. VCAM-1/alpha 4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders. J. Allergy. Clin. Immunol., 1996, 98, S270-7.
11. Mach, F.; Schonbeck, U.; Sukhova, G.K.; Atkinson, E.; Libby, P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature, 1998, 394, 200-3.
12. Chothia, C. The molecular structure of cell adhesion molecules. Annu. Rev. Biochem., 1997, 66, 823-62.
13. Mandell, K.J.; Parkos, C.A. The JAM family of proteins. Adv. Drug Deliv. Rev., 2005, 57, 857-67.
14. Smalley, D.M.; Lin, J.H.; Curtis, M.L.; Kobari, Y.; Stemerman, M.B.; Pritchard, K.A. Jr. Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1. Arterioscler. Thromb. Vasc. Biol., 1996, 16, 585-90.
15. Verna, L.; Ganda, C.; Stemerman, M.B. In vivo low-density lipoprotein exposure induces intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 correlated with activator protein-1 expression. Arterioscler. Thromb. Vasc. Biol., 2006, 26, 1344-9.
16. Davies, M.J.; Gordon, J.L.; Gearing, A.J.; Pigott, R.; Woolf, N.; Katz, D.; Kyriakopoulos, A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J. Pathol., 1993, 171, 223-9.
17. Patel, S.S.; Thiagarajan, R.; Willerson, J.T.; Yeh, E.T. Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation, 1998, 97, 75-81.
18. Nageh, M.F.; Sandberg, E.T.; Marotti, K.R.; Lin, A.H.; Melchior, E.P.; Bullard, D.C.; Beaudet, A.L. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol., 1997, 17, 1517-20.
19. Cybulsky, M.I.; Gimbrone, M.A. Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science, 1991, 251, 788-91.
20. Ramana, K.V.; Bhatnagar, A.; Srivastava, S.K. Inhibition of aldose reductase attenuates TNF-alpha-induced expression of adhesion molecules in endothelial cells. FASEB. J., 2004, 18, 1209-18.
21. Li, H.; Cybulsky, M.I.; Gimbrone, M.A. Jr., Libby, P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb., 1993, 13, 197-204.
22. Kawakami, A.; Aikawa, M.; Alcaide, P.; Luscinskas, F.W.; Libby, P.; Sacks, F.M. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation, 2006, 114, 681-7.
23. Huo, Y.; Hafezi-Moghadam, A.; Ley, K. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ. Res., 2000, 87, 153-9.
24. Cybulsky, M.I.; Iiyama, K.; Li, H.; Zhu, S.; Chen, M.; Iiyama, M.; Davis, V.; Gutierrez-Ramos, J.C.; Connelly, P.W.; Milstone, D.S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest., 2001, 107, 1255-62.
25. Newman, P.J.; Newman, D.K. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 953-64.
26. Tzima, E.; Irani-Tehrani, M.; Kiosses, W.B.; Dejana, E.; Schultz, D.A.; Engelhardt, B.; Cao, G.; DeLisser, H.; Schwartz, M.A. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature, 2005, 437, 426-31.
27. Li, C.; Mollahan, P.; Baguneid, M.S.; McMahon, R.F.; Kumar, P.; Walker, M.G.; Freemont, A.J.; Kumar, S. A comparative study of neovascularisation in atherosclerotic plaques using CD31, CD105 and transforminggrowthfactor (TGF) beta 1. Pathobiology, 2006, 73, 192-7.
28. Gebuhrer, V.; Murphy, J.F.; Bordet, J.C.; Reck, M.P.; McGregor, J.L. Oxidized low-density lipoprotein induces the expression of Pselectin (GMP140/PADGEM/CD62) on human endothelial cells. Biochem. J., 1995, 306(Pt 1), 293-8.
29. Chen, H.; Li, D.; Saldeen, T.; Mehta, J.L. Transforming growth factor-beta(1) modulates oxidatively modified LDL-induced expression of adhesion molecules: role of LOX-1. Circ. Res., 2001, 89, 1155-60.
30. Ramos, C.L.; Huo, Y.; Jung, U.; Ghosh, S.; Manka, D.R.; Sarembock, I.J.; Ley, K. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ. Res., 1999, 84, 1237-44.
31. Manka, D.; Collins, R.G.; Ley, K.; Beaudet, A.L.; Sarembock, I.J. Absence of P-Selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial Injury in apolipoprotein E-deficient mice. Circulation, 2001, 103, 1000-5.
32. Stocker, C.J.; Sugars, K.L.; Harari, O.A.; Landis, R.C.; Morley, B.J.; Haskard, D.O. TNF-alpha, IL-4, and IFN-gamma regulate differential expression of Pand E-selectin expression by porcine aortic endothelial cells. J. Immunol., 2000, 164, 3309-15.
33. Collins, R.G.; Velji, R.; Guevara, N.V.; Hicks, M.J.; Chan, L.; Beaudet, A.L. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J. Exp. Med., 2000, 191, 189-94.
34. Dong, Z.M.; Chapman, S.M.; Brown, A.A.; Frenette, P.S.; Hynes, R.O.; Wagner, D.D. The combined role of P- and E-selectins in atherosclerosis. J. Clin. Invest., 1998, 102, 145-52.
35. Galkina, E.; Kadl, A.; Sanders, J.; Varughese, D.; Sarembock, I.J.; Ley, K. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med., 2006, 203, 1273-82.
36. Eriksson, E.E.; Xie, X.; Werr, J.; Thoren, P.; Lindbom, L. Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J. Exp. Med., 2001, 194, 205-18.
37. Babinska, A.; Azari, B.M.; Salifu, M.O.; Liu, R.; Jiang, X.C.; Sobocka, M.B.; Boo, D.; Al, K.G.; Deitch, J.S.; Marmur, J.D.; Ehrlich, Y.H.; Kornecki, E. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques. Thromb. Haemost., 2007, 97, 272-81.
38. Ostermann, G.; Fraemohs, L.; Baltus, T.; Schober, A.; Lietz, M.; Zernecke, A.; Liehn, E.A.; Weber, C. Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 729-35.
39. Zernecke, A.; Liehn, E.A.; Fraemohs, L.; von Hundelshausen, P.; Koenen, R.R.; Corada, M.; Dejana, E.; Weber, C. Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler. Thromb. Vasc. Biol., 2006, 26, e10-e13.
40. Cunningham, S.A.; Rodriguez, J.M.; Arrate, M.P.; Tran, T.M.; Brock, T.A. JAM2 interacts with alpha4beta1. Facilitation by JAM3. J. Biol. Chem., 2002, 277, 27589-92.
41. Keiper, T.; Al-Fakhri, N.; Chavakis, E.; Athanasopoulos, A.N.; Isermann, B.; Herzog, S.; Saffrich, R.; Hersemeyer, K.; Bohle, R.M.; Haendeler, J.; Preissner, K.T.; Santoso, S.; Chavakis, T. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDLmediated leukocyte recruitment. FASEB. J., 2005, 19, 2078-80.
42. Lin, C.P.; Chen, Y.H.; Lin, W.T.; Leu, H.B.; Liu, T.Z.; Huang, S.L.; Chen, J.W. Direct effect of statins on homocysteine induced endothelial adhesiveness: potential impact to human atherosclerosis. Eur. J. Clin. Invest., 2008, 38, 106-16.
43. Koh, K.K.; Son, J.W.; Ahn, J.Y.; Jin, D.K.; Kim, H.S.; Choi, Y.M.; Ahn, T.H.; Kim, D.S.; Shin, E.K. Vascular effects of diet and statin in hypercholesterolemic patients. Int. J. Cardiol., 2004, 95, 185-91.
44. Serrano, Jr. C.V.; Pesaro, A.E.; de Lemos, J.A.; Rached, F.; Segre, C.A.; Gomes, F.; Ribeiro, A.F.; Nicolau, J.C.; Yoshida, V.M.; Monteiro, H.P. Native LDL-cholesterol mediated monocyte adhesion molecule overexpression is blocked by simvastatin. Cardiovasc. Drugs. Ther., 2009, 23, 215-20.
45. Weber, C.; Erl, W.; Pietsch, A.; Weber, P.C. Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation, 1995, 91, 1914-7.
46. Walter, T.; Szabo, S.; Kazmaier, S.; Swoboda, S.; Suselbeck, T.; Brueckmann, M.; Borggrefe, M.; Beyer, M.E; Hoffmeister, H.M. Effects of clopidogrel on adhesion molecules, hemostasis, and fibriolysis in coronary heart disease. J. Cardiov. Pharmacol., 2008, 51, 616-20.
47. Xiao, Z.; Theroux, P. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with acute coronary syndrome. J. Am. Coll. Cardiol., 2004, 43, 1982-8.
48. Nannizzi-Alaimo, L.; Alves, V.L.; Phillips, D.R. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40L ligand during platelet stimulation. Circulation, 2003, 107, 1123-8.
49. Ercan, E.; Bozdemir, H.; Tengiz, I.; Sekuri, C.; Aliyev, E.; Akilli, A.; Akin, M. Decreased soluble cell adhesion molecules after tirofiban infusion in patients with unstable angina pectoris. Thrombosis Journal, 2004, 2, 1-6.
50. Mitchell, J.A.; Warner, T.D. COX isoforms in the cardiovascular system: Understanding the activities of the non-steroidal antiinflammatory drugs. Nat. Rev. Drug Discov., 2006, 5, 75-86.
51. Rott, D.; Zhu, J.; Burnett, M.S.; Zhou, Y.F.; Zalles-Ganley, A.; Ogunmakinwa, J.; Epstein, S.E. Effects of MF-tricyclic, a selective cyclooxygenase 2 inhibitor, on atherosclerosis progression and susceptility to cytomegalovirus replication in apoprotein-E knockout mice. J. Am. Coll. Cardiol., 2003, 41, 1812-9.
52. Kopp, E.; Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science, 1994, 265, 956-9.
53. Kapiotis, S.; Sengoelge, G.; Sperr, W.R.; Baghestanian, M.; Quehenberger, P.; Bevec, D.; Li, S.R.; Menzel, E.J.; Mlihl, A.; Zapolska, D.; Virgolini, I.; Valent, P.; Speiser, W. Ibuprofen inhibits pyrogen-dependent expression of VCAM-l and ICAM-l on human endothelial cells. Life Sci., 1996, 58, 2167-81.
54. Sakai, A. Diclofenac inhibits endothelial cell adhesion molecule expression induced with lipopolysaccharide. Life Sci., 1996, 58, 2377-87.
55. Gonzalez-Alvaro, I.; Munoz, C.; Garcia-Vicuna, R.; Sabando, P.; Cabmas, C.; Sanchez-Madrid, F.; Diaz-Gonzale, F. Interference of nonsteroidal anti-inflammatory drugs with very late activation antigen 4/vascular adhesion molecule 1-mediated lymphocyteendothelial cell adhesion. Arthritis. Rheumatism, 1998, 41, 1677-88.
56. Jacob, S.; Laury-Kleintop, L.; Lanza-Jacoby, S. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice. J. Surg. Res., 2008, 146, 135-42.
57. Cato, A.C.; Wade, E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioassays., 1996, 18, 371-8.
58. Liden, J.; Rafter, I.; Truss, M.; Gustafsson, J.A.; Okret, S. Glucocorticoid effect on NF-κB binding in the transcription of the ICAM-1 gene. Biochem. Biophys. Res. Commun., 2000, 273, 1008-14.
59. Brostjan, C.; Anrather, J.; Csizmadia, V.; Natajaran, C.; Winkler, H. Glucocorticoids inhibit E-selectin expression by targeting NF-κB and not ATF/c-Jun. J. Immunol., 1997, 158, 3836-44.
60. Cronstein, B.N.; Molad, Y.; Reibman, J.; Balakhane, E.; Levini, R.I.; Weissmann, G. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J. Clin. Invest., 1995, 96, 994-1002.
61. Asako, H.; Kubes, P.; Paethge, B.A.; Wolf, R.E.; Grancer, D.N. Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesentric venules. Inflammation, 1992, 16, 45-56.
62. Dolhain, R.J.; Tak, P.P.; Dijkmans, B.A.; De Kuiper, P.; Breevld, F.C.; Miltenburg, A.M. Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. Br. J. Rheumatol., 1998, 37, 502-8.
63. Bratt, J.; Belcher, J.; Vercellotti, G.M.; Palmblad, J. Effects of antirheumatic gold salts on NF-κB mobilization and tumor necrosis factor-κ-induced neutrophil-dependent cytotoxicity for human endothelial cells. Clin. Exp. Immunol., 2000, 120, 79-84.
64. Lorenz, H.M.; Grunke, M.; Hieronymus, T.; Antoni, C.; Grusslein, H.; Schaible, T.F.; Manger, B.; Kalden, J.R. In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2. J. Rheumatol., 2000, 27, 304-10.
65. Neuner, P.; Klosner, G.; Pourmojib, M.; Knobler, R.; Schwartz, T. Pentoxifylline in vivo and in vitro down-regulate the expression of the intercellular adhesion molecule-1 in monocytes. Immunology, 1997, 90, 435-9.
66. Wang, W.; Tam, W.F.; Hughes, C.C.W.; Rath, S.; Sen, R. cRel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation. Immunity, 1997, 6, 165-74.
67. Coon, M.E.; Diegel, M.; Leshinsky, N.; Klaus, S.J. Selective pharmacologic inhibition of murine and human IL-12-dependent Th1 differentiation and IL-12 signaling. J. Immunol., 1999, 163, 6567-74.
68. Maksymowych, W.P.; Avina-Zubieta, A.; Loung, M.H.; Russell, A.S. An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis. J. Rheumatol., 1995, 22, 625-9.
69. Okudy, Y.; Sakoda, S.; Fujimura, H.; Yanagihara, T. Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells. Immunopharmacology, 1996, 35, 141-8.
70. Lauterbach, R.; Pawlik, D.; Kowalczik, D.; Ksiycinski, W.; Helwich, E.; Zembala, M. Effect of the immunomoderating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: A placebo-controlled double-blind trial. Crit. Care Med., 1999, 27, 807-14.
71. Ciprandi, G.; Passalacqua, G.; Canonica, G.W. Effects of H1 antihistamines on adhesion molecules: A possible rationale for long-term treatment. Clin. Exp. Allergy, 1999, 29, 49-53.
72. Charreau, B.; Coupel, S.; Goret, F.; Pourcel, C.; Soulillou, J.P. Association of glucocorticoids and cyclosporine A or rapamycin prevents E-selectin and IL-8 expression during LPS- and TNFalpha- mediated endothelial cell activation. Transplantation, 2000, 69, 945-53.
73. Allison, A.C.; Eugui, E.M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology, 2000, 47, 85-118.
74. Meng, C.Q.; Somers, P.K.; Rachita, C.L.; Holt, L.A.; Hoong, L.K.; Zheng, S.; Simpson, J.E.; Hill, R.R.; Olliff, L.K.; Kunsch, C.K.; Sundell, C.L.; Parthasarathy, S.; Saxena, U.; Sikorski, J.A.; Wasserman, M.A. Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis. Bioorganic. & Medicinal. Chemistry Letters, 2002, 12, 2545-8.
75. Cayatte, A.j.; Rupin, A.; Oliver-Krasinski, J.; Maitland, K.; Sansilvestri-Morel, P.; Boussard, M.F.; Wierzbicki, M.; Verbeuren, T.J. S17834, a new inhibitor of cell adhesion and atherosclerosis that targets NADPH oxidase. Arterioscler. Thromb. Vasc. Biol., 2001, 21, 1577-84.
76. Pillarisetti, S.; Alexander, C.W.; Saxena, U. Atherosclerosis-new targets and therapeutics. Curr. Med. Chem. - Cardiovascular. & Hematological. Agents, 2004, 2, 327-34.
77. Calixto, J.B.; Campos, M.M.; Otuki, M.F.; Santos, A.R.S. Antiinflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokins and adhesion molecules. Planta. Med., 2004, 70, 93-103.
78. Kleijnen, J.; Knipschild, P. Ginkgo biloba. Lancet, 1992, 340,1136-9.
79. Chen, J.W.; Chen, Y.H.; Lin, F.Y.; Chen, Y.L.; Lin, S.J. Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 1559-66.
80. Ling, S.; Dai, A.; Guo, Z.; Lou, L.; Komesaroff, P.A. A preparation of herbal medicine Salvia miltiorrhiza reduces expression of intercellular adhesion molecule-1 and development of atherosclerosis in apolipoprotein E-deficient mice. J. Cardiov. Pharm., 2008, 51, 38-44.
81. Ren, D.C.; Du, G.H.; Zhang, J.T. Inhibitory effect of the watersoluble extract of Salvia miltiorrhiza on neutrophil-endothelial adhesion. Jpn. J. Pharmacol., 2002, 90, 276-80.
82. Ling, S.; Nheu, L.; Dai, A.; Guo, Z.X.; Komesaroff, P.A. Effects of four medicinal herbs on human vascular endothelial cells in culture. Intern. J. Cardiol., 2008, 128, 350-8.
83. Chen, Y.H.; Lin, S.J.; Ku, H.H.; Shiao, M.S.; Lin, F.Y.; Chen, J.W.; Chen, Y.L. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF--α-treated human aortic endothelial cells. J. Cell Biochem., 2001, 82, 512-21.
84. Zhou, Z.; Liu, Y.; Miao, A.D.; Wang, S.Q. Protocatechuic aldehyde suppresses TNF-ainduced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells. European J. Pharmacology, 2005, 513, 1-8.
85. Ding, M.; Zhao, G.R.; Yuan, T.J.; Guo, Z.X. Aqueous extract of Salvia miltiorrhiza regulates adhesion molecule expression of TNFa- induced endothelial cells by blocking activation of nuclear factor κB. J. Cardiovasc. Pharmacol., 2005, 45, 516-24.
86. O'Brien, K.A.; Ling, S.; Abbas, E.; Zhang, J.S.; Dai, A.; Bensoussan, A.; Xin, G.Z.; Rui, L.; Komesaroff, P.A. A Chinese herbal preparation containing polygonum multiflorum and radix salviae miltiorrhizae reduces cardiovascular disease risk. Evidence Based Complementary and Alternative Medicine, 2008, Sep 27 (online publication).